Abstract
Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal neoplasm involving various organs. Approximately 70 cases of gynecologic PEComas have been reported in the literature. Due to the paucity of cases, there is no definite treatment regimen established. We describe disease progression in a case of uterine PEComa with pulmonary metastasis in a 37-year-old woman who had been treated with surgery and various regimens of adjuvant treatment including vincristine, ifosfamide, cisplatin, sirolimus, doxorubicin, olaratumab, pazopanib and dacarbazine. Adequate management and prognosis still seem inconclusive and further case reports with randomized trials are needed to delineate the nature of this neoplasm.
| Original language | English |
|---|---|
| Pages (from-to) | 495-499 |
| Number of pages | 5 |
| Journal | European Journal of Gynaecological Oncology |
| Volume | 41 |
| Issue number | 4 |
| DOIs | |
| State | Published - 15 Aug 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adjuvant chemotherapy
- Dacarbazine
- Perivascular epithelioid cell tumor (PEComa)
- Sirolimus
- Uterus
- Vincristine
Fingerprint
Dive into the research topics of 'Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver